Showing results (221-230 of 301) with videos related to

Sort By:
Pageof 31
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 1, 2008
Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody can prevent rat cardiac allograft rejectionYusuke Kitazawa, Masayuki Fujino, Takatoshi Sakai, et al.
Japanese Journal of Clinical Oncology|March 12, 2026
Real-world comparison of enzalutamide and apalutamide in metastatic hormone-sensitive prostate cancer: a multi-institutional propensity score-matched analysisKazuki Nishimura, Kensuke Hirosuna, Heima Niigawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 23, 2025
Current Kidney-Preserving Strategies for Upper Tract Urothelial CarcinomaTeruo Inamoto, Shunsuke Watanabe, Yoshihiro Tsuchiya, et al.
Biomedical Reports|January 3, 2024
Bronchogenic cysts in rare sites (retroperitoneum, skin, spinal cord and pericardial cavity): A case series and characterization of epithelial phenotypesYusuke Onishi, Shigeru Kawabata, Emi Yasuda, et al.
Anticancer Research|August 21, 2003
Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl-dependent pathway and impairment in ERK activityHaruhito Azuma, Shigeo Horie, Satoru Muto, et al.
World Journal of Urology|February 24, 2025
Deciphering RCC immunotherapy outcomes: insights from a Japanese multi-institutional study on the CANLPH score's impactTatsuo Fukushima, Takuya Tsujino, Moritoshi Sakamoto, et al.
Targeted Oncology|May 28, 2024
C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial CarcinomaTaizo Uchimoto, Takuya Matsuda, Kazumasa Komura, et al.
Asian Journal of Endoscopic Surgery|June 4, 2025
Comparing Perioperative Outcomes Using Single and Multiple Robot Systems During the Learning Period for Robot-Assisted Radical ProstatectomyYuto Matsushita, Yoshihiro Tsuchiya, Gaku Ishikawa, et al.
Anticancer Research|December 31, 2024
Comparing Immuno-oncology Combination Therapy With Tyrosine Kinase Inhibitor Monotherapy for Advanced Renal Cell CarcinomaGaku Ishikawa, Keita Tamura, Yoshihiro Tsuchiya, et al.
Targeted Oncology|March 28, 2024
Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint InhibitorsTaizo Uchimoto, Shuya Tsuchida, Kazumasa Komura, et al.
Pageof 31